Effects of Amniotic Membrane Extract on the Hyperplastic Response of the Middle Ear Mucosa in a Bacterially-Induced Otitis Media Rat Model: A Preliminary Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. Human amniotic membrane extract (AME) is known to contain numerous bioactive factors and anti-inflammatory substances. However, the anti-inflammatory effects of AME on the middle ear (ME) mucosa are unclear. This study assessed the effects of AME on the growth of the ME mucosa in response to bacterially-induced otitis media (OM). Methods. OM was induced by inoculating nontypeable Haemophilus influenzae (NTHi) into the ME cavity of rats. ME mucosal explants were cultured in AME concentrations of 0, 5, 10, or 50 μg/mL. The area of explant outgrowth was measured in culture and analyzed at 1, 3, 5, and 7 days after explantation. The expression of Ki-67, mucin 5AC (MUC5AC), tumor necrosis factor-α (TNF-α), and interleukin-10 (IL-10) in the explants was also evaluated using quantitative polymerase chain reaction (PCR) and immunocytochemistry (ICC). Results. The NTHi-induced ME mucosa growth increased gradually over the 7-day culture period in all explants at different AME concentrations. There was a trend for mucosal growth inhibition at higher concentrations of AME, although the growth was not significantly different among the groups until day 5. The ME mucosal explants treated with the 50 μg/mL concentration of AME showed significantly suppressed growth on postexplantation day 7 compared with other explants on the same day. PCR and ICC staining revealed that the expression of Ki-67, MUC5AC, TNF-α, and IL-10 further decreased in the explants with higher concentrations of AME than in those with lower concentrations of AME. Conclusion. Our results showed that higher concentrations of AME reduced the mucosal proliferative response in bacterial OM in rats. These findings provide evidence that AME has an influence on the inflammatory and proliferative responses to NTHi infection in ME mucosa.
Abstract
Objectives. Human amniotic membrane extract (AME) is known to contain numerous bioactive factors and anti-inflammatory substances. However, the anti-inflammatory effects of AME on the middle ear (ME) mucosa are unclear. This study assessed the effects of AME on the growth of the ME mucosa in response to bacterially-induced otitis media (OM). Methods. OM was induced by inoculating nontypeable Haemophilus influenzae (NTHi) into the ME cavity of rats. ME mucosal explants were cultured in AME concentrations of 0, 5, 10, or 50 μg/mL. The area of explant outgrowth was measured in culture and analyzed at 1, 3, 5, and 7 days after explantation. The expression of Ki-67, mucin 5AC (MUC5AC), tumor necrosis factor-α (TNF-α), and interleukin-10 (IL-10) in the explants was also evaluated using quantitative polymerase chain reaction (PCR) and immunocytochemistry (ICC). Results. The NTHi-induced ME mucosa growth increased gradually over the 7-day culture period in all explants at different AME concentrations. There was a trend for mucosal growth inhibition at higher concentrations of AME, although the growth was not significantly different among the groups until day 5. The ME mucosal explants treated with the 50 μg/mL concentration of AME showed significantly suppressed growth on postexplantation day 7 compared with other explants on the same day. PCR and ICC staining revealed that the expression of Ki-67, MUC5AC, TNF-α, and IL-10 further decreased in the explants with higher concentrations of AME than in those with lower concentrations of AME. Conclusion. Our results showed that higher concentrations of AME reduced the mucosal proliferative response in bacterial OM in rats. These findings provide evidence that AME has an influence on the inflammatory and proliferative responses to NTHi infection in ME mucosa.
참고문헌 (40)
- Coticchia JM, "New paradigms in the pathogenesis of otitis media in children", Front Pediatr, 1, pp.52~ (2013)
- Rovers MM, "Otitis media", Lancet, 363(9407), pp.465~473 (2004)
- Infante-Rivard C, "Otitis media in children : frequency, risk factors, and research avenues", Epidemiol Rev, 15(2), pp.444~465 (1993)
- Klein JO, "The burden of otitis media", Vaccine, 19(Suppl 1), pp.S2~S8 (2000)
- Al Khabori M, "The prevalence and causes of hearing impairment in Oman : a community-based cross-sectional study", Int J Audiol, 43(8), pp.486~492 (2004)
- Heikkinen T, "Importance of respiratory viruses in acute otitis media", Clin Microbiol Rev, 16(2), pp.230~241 (2003)
- Teele DW, "Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group", J Infect Dis, 162(3), pp.685~694 (1990)
- Lim DJ, "Ultrastructural pathology of the middle ear mucosa in serous otitis media", Ann Otol Rhinol Laryngol, 80(6), pp.838~853 (1971)
- Tos M, "Mucous glands in the middle ear : what is known and what is not", ORL J Otorhinolaryngol Relat Spec, 64(2), pp.86~94 (2002)
- Bluestone CD, "Pediatric otolaryngology", pp.356~512 (1983), Saunders
- Schuknecht HF, "Pathology of the ear" (1993), Lea & Febiger
- Ryan AF, "Secondary immune response in the middle ear: immunological, morphological, and physiological observations", Ann Otol Rhinol Laryngol, 95(3 Pt 1), pp.242~249 (1986)
- Cho CG, "Both canonical and non-canonical NF-κB activation contribute to the proliferative response of the middle ear mucosa during bacterial infection", Innate Immun, 22(8), pp.626~634 (2016)
- Hernandez M, "Myeloid differentiation primary response gene 88 is required for the resolution of otitis media", J Infect Dis, 198(12), pp.1862~1869 (2008)
- Leichtle A, "TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media", Innate Immun, 15(4), pp.205~215 (2009)
- Ryan AF, "Mouse models of induced otitis media", Brain Res, 1091(1), pp.3~8 (2006)
- Palacios SD, "Participation of Ras and extracellular regulated kinase in the hyperplastic response of middle-ear mucosa during bacterial otitis media", J Infect Dis, 186(12), pp.1761~1769 (2002)
- Silini A, "Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies", Curr Stem Cell Res Ther, 8(1), pp.6~14 (2013)
- Ricci E, "Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model", Cell Tissue Bank, 14(3), pp.475~488 (2013)
- Hao Y, "Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane", Cornea, 19(3), pp.348~352 (2000)
- Faulk WP, "Human amnion as an adjunct in wound healing", Lancet, 1(8179), pp.1156~1158 (1980)
- Bailo M, "Engraftment potential of human amnion and chorion cells derived from term placenta", Transplantation, 78(10), pp.1439~1448 (2004)
- Talmi YP, "Antibacterial properties of human amniotic membranes", Placenta, 12(3), pp.285~288 (1991)
- Kjaergaard N, "Antibacterial properties of human amnion and chorion in vitro", Eur J Obstet Gynecol Reprod Biol, 94(2), pp.224~229 (2001)
- Sangwan VS, "Antimicrobial properties of amniotic membrane", Br J Ophthalmol, 95(1), pp.1~2 (2011)
- Gheorghe A, "New clinical application of amniotic membrane transplant for ocular surface disease", J Med Life, 9(2), pp.177~179 (2016)
- Mohan R, "Human amnion membrane : potential applications in oral and periodontal field", J Int Soc Prev Community Dent, 7(1), pp.15~21 (2017)
- Mamede AC, "Amniotic membrane : from structure and functions to clinical applications", Cell Tissue Res, 349(2), pp.447~458 (2012)
- Guo Q, "A comparison of the effectiveness between amniotic membrane homogenate and transplanted amniotic membrane in healing corneal damage in a rabbit model", Acta Ophthalmol, 89(4), pp.e315~e319 (2011)
- Mahbod M, "Amniotic membrane extract preparation: what is the best method?", J Ophthalmic Vis Res, 9(3), pp.314~319 (2014)
- Yadav MK, "Antimicrobial and antibiofilm effects of human amniotic", chorionic membrane extract on Streptococcus pneumoniae, 2017, pp.8, 1948~
- Cho CG, "Role of group 3 innate lymphoid cells during experimental otitis media in a rat model", Int J Pediatr Otorhinolaryngol, 88, pp.146~152 (2016)
- Yu GH, "Expression of surfactant Protein-A in the Haemophilus influenzae-induced otitis media in a rat model", Int J Pediatr Otorhinolaryngol, 112, pp.61~66 (2018)
- Go YY, "Promotion of osteogenic differentiation by amnion", chorion membrane extracts, 2016, pp.14(2), e171~e180
- Go YY, "Differential effects of amnion and chorion membrane extracts on osteoblast-like cells due to the different growth factor composition of the extracts", PLoS One, 12(8), pp.e0182716~ (2017)
- Kim HA, "Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice", Int Immunopharmacol, 7(10), pp.1286~1291 (2007)
- He H, "Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract", Invest Ophthalmol Vis Sci, 49(10), pp.4468~4475 (2008)
- Li W, "Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro", Exp Eye Res, 82(2), pp.282~292 (2006)
- Scholzen T, "The Ki-67 protein : from the known and the unknown", J Cell Physiol, 182(3), pp.311~322 (2000)
- Wang G, "Genes associated with MUC5AC expression in small airway epithelium of human smokers and non-smokers", BMC Med Genomics, 5, pp.21~ (2012)
